See also this year's filing and all EDGAR filings for this company.
PDF Report 0001525040_2012_American_Renal_Associates_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'American International Holdings CORP', 'shared_tokens': {'american'}}, {'other_company': 'American Renal Holdings Inc', 'shared_tokens': {'american', 'renal'}}]} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001525040, American Renal Associates Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 539,461,000 |
| 1 | AssetsNonCurrent | 1,734,000 |
| 2 | AssetsCurrent | 109,224,000 |
| 3 | PropertyPlantAndEquipment | 72,416,000 |
| 4 | remainder_Assets | 4,962,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 57,587,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 39,326,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 217,036,000 |
| 13 | DepreciationDepletionAndAmortization | 17,865,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 45,418,000 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 360,081,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 727,797,000 |
| 1 | Liabilities | 57,587,000 |
| 2 | Expenses | 319,645,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 670,210,000 |
| 5 | NetIncome | 40,436,000 |
| 6 | ComprehensiveNetIncome | 40,436,000 |
| 7 | BaseVar | 732,555,000 |
| 8 | EconomicCapitalRatio | 4.85 |
Edgar->Model Mapping
Feature Distribution
